Literature DB >> 26508473

Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.

Jae-Young Park1, Ji-Youn Sung2, Juhie Lee2, Yong-Koo Park2, Youn Wha Kim2, Gou Young Kim3, Kyu Yeoun Won3, Sung-Jig Lim4.   

Abstract

PURPOSE: Tumor-associated macrophages (TAMs) play a significant role in tumor progression and angiogenesis. However, the prognostic value of TAMs in different histologic locations of gastric cancer (GC) is still unknown. We evaluated the distribution of TAMs in different histologic locations to investigate its importance in predicting prognosis and the relationship with angiogenesis and CXCL12 expression in GC. METHODS AND MATERIALS: The distribution of TAMs and microvessel density (MVD) in 113 GC samples were evaluated by immunohistochemical staining of CD163 and CD105, respectively. The extent of TAM distribution in the tumor was categorized into three groups: infiltrated TAMs in the tumor nest (TN), tumor stroma (TS) and invasive tumor margin (TM). The expression of CXCL12 in GC were evaluated by immunohistochemical staining of tissues from 88 GC samples.
RESULTS: The increased CD163+ TAMs in TS and TM were closely correlated with tumor size, depth of invasion, TNM stage, lymph node metastasis, and lymphovascular invasion. TAMs in TN was not related with any clinicopathologic characteristics except histologic differentiation. The high infiltration of CD163+ TAMs in TS and TM were significantly correlated with poor overall survival. Regardless of location, CD163+ TAMs were significantly correlated with increased MVD. CXCL12 expression was significantly associated with increased CD163+ TAMs in TS and TM.
CONCLUSIONS: TAMs in different histologic locations in GC were related to distinct aspects of tumor progression. CD163+ TAMs in TS and TM are associated with tumor progression and CXCL12 expression in GC. TAMs may be involved in tumor progression through the angiogenesis.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26508473     DOI: 10.1016/j.clinre.2015.09.005

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  45 in total

1.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

Review 2.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 3.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

Review 4.  Tumor-associated macrophages: role in cancer development and therapeutic implications.

Authors:  Arash Salmaninejad; Saeed Farajzadeh Valilou; Arash Soltani; Sepideh Ahmadi; Yousef Jafari Abarghan; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  Cell Oncol (Dordr)       Date:  2019-05-29       Impact factor: 6.730

5.  Heme catabolism by tumor-associated macrophages controls metastasis formation.

Authors:  Francesca Maria Consonni; Augusto Bleve; Maria Grazia Totaro; Mariangela Storto; Paolo Kunderfranco; Alberto Termanini; Fabio Pasqualini; Chiara Alì; Chiara Pandolfo; Francesco Sgambelluri; Giulia Grazia; Mario Santinami; Andrea Maurichi; Massimo Milione; Marco Erreni; Andrea Doni; Marco Fabbri; Laura Gribaldo; Eliana Rulli; Miguel Parreira Soares; Valter Torri; Roberta Mortarini; Andrea Anichini; Antonio Sica
Journal:  Nat Immunol       Date:  2021-04-26       Impact factor: 25.606

6.  Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma.

Authors:  Hao Cai; Xiao-Dong Zhu; Jian-Yang Ao; Bo-Gen Ye; Yuan-Yuan Zhang; Zong-Tao Chai; Cheng-Hao Wang; Wen-Kai Shi; Man-Qing Cao; Xiao-Long Li; Hui-Chuan Sun
Journal:  Oncoimmunology       Date:  2017-05-26       Impact factor: 8.110

Review 7.  The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.

Authors:  Changbin Zhu; Johan M Kros; Caroline Cheng; Dana Mustafa
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 8.  Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.

Authors:  Hui-Ying Ma; Xin-Zhou Liu; Chun-Min Liang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 9.  Diverse Functions of Macrophages in Different Tumor Microenvironments.

Authors:  Ming Yang; Daniel McKay; Jeffrey W Pollard; Claire E Lewis
Journal:  Cancer Res       Date:  2018-09-11       Impact factor: 12.701

Review 10.  New insights into M1/M2 macrophages: key modulators in cancer progression.

Authors:  Jiuyang Liu; Xiafei Geng; Jinxuan Hou; Gaosong Wu
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.